news aktuell GmbH

R-Biopharm AG: Flu tests from R-Biopharm also detect new virus variants

25.11.2022 11:23:27 CET | news aktuell GmbH | Press release

Share
Detect reliably the current flu virus variants: The RIDA®GENE flu assays from R-Biopharm
Picture: Getty Images
Detect reliably the current flu virus variants: The RIDA®GENE flu assays from R-Biopharm Picture: Getty Images

Darmstadt, November 25, 2022: The flu season has begun and different virus variants are also circulating in Germany. With the flu tests from biotechnology company R-Biopharm, patients quickly have certainty: Its RIDA®GENE Flu assays also reliably detect the two novel variants. The company made the announcement with regard to influenza A H1N1pdm09, which is circulating primarily in the United Kingdom, and the H3N2 subtype, which was rampant in Denmark in the spring and is currently dominating influenza activity in Germany.

 "Mutations in the target gene (MP gene) can affect the diagnostic performance of influenza screening assays, producing false-negative test results," explains Dr. Andreas Simons, Head of Product Management at R-Biopharm. " Alignments of the detection systems we used with the described sequences of the two novel virus variants showed no mismatches. Their reliable detection is not affected by the described mutations."

This means laboratories can continue to reliably confirm or rule out influenza infections using R-Biopharm's RIDA®GENE (PG0505, PG0545, PG6825) assays. The tests are multiplex real-time RT-PCR for the direct qualitative detection of influenza viruses.

About R-Biopharm

 R-Biopharm AG, located in Darmstadt, is one of Germany's leading biotechnology companies. Founded in 1988, the company is family-run in the second generation and considers itself as a pioneer for health and quality of life. Its aspiration: to provide the highest possible precision, safety, clarity and certainty in prevention, therapy and healing. To this end, R-Biopharm develops technologies, products and solutions for Clinical Diagnostics, Nutrition Care and Food and Feed Analytics – and does so in internationally recognized top quality. R-Biopharm is the world market leader for test systems in the field of allergen analysis.

R-Biopharm unites research, development and sales under one roof in order to respond to ever new challenges with agile processes and to accompany the steadily growing world population into a new health era. The company is represented in more than 120 countries – through 29 subsidiaries and 120 distributors. It employs around 1,400 people worldwide (690 at its headquarters in Darmstadt) and was repeatedly recognized with the "Sustainability Award" for sustainable and profitable growth.

Press contact:

Simone Feiler
Head of Corporate Brand Communication

https://r-biopharm.com/de

https://r-biopharm.com/de/kontakt/presse

https://r-biopharm.com/de/news-presse/download-galerie

R-Biopharm AG

An der neuen Bergstraße 17

64297 Darmstadt

Phone: 0 61 51 - 81 02-538

Mobile: 0 160 - 55 273 60

Fax: 0 61 51 - 81 02-40

Email: s.feiler@r-biopharm.de

Images

Detect reliably the current flu virus variants: The RIDA®GENE flu assays from R-Biopharm
Picture: Getty Images
Detect reliably the current flu virus variants: The RIDA®GENE flu assays from R-Biopharm Picture: Getty Images
Download

About news aktuell GmbH

news aktuell GmbH
news aktuell GmbH
Mittelweg 144
20148 Hamburg

+49 (0)40 4113-32589http://www.newsaktuell.de

news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

World’s first clearing bank for the AI era: Augustus receives conditional full service bank charter from the OCC12.5.2026 10:00:00 CEST | Press release

New York - Augustus, formerly known as Ivy, has received conditional approval from the Office of the Comptroller of the Currency (OCC), the US federal banking regulator, to establish Augustus Bank, N.A. as a full service US national bank. Augustus Bank N.A. will be the world’s first clearing bank for the AI era, built on a stablecoin and AI-native core – a bank that’s always open, made for machines, at the speed of compute.

Innomotics accelerates LNG electrification with major eLNG drive orders worldwide11.5.2026 13:37:15 CEST | Press release

Innomotics wins several orders to provide motor and drive technology for eLNG projects, totaling a volume in the higher double-digit million EUR range Innomotics advances electrification of LNG production with eLNG solutions based on electric drive systems Significant operational, environmental, and financial benefits compared to conventional turbine-based LNG plants Enables decarbonization and supports global transition to sustainable energy systems

Global governance report highlights future shock risks as democratic accountability slips and state capacity plateaus7.5.2026 08:50:33 CEST | Press release

Los Angeles/DNA - The newly released 2026 Berggruen Governance Index (BGI) paints a mixed picture of global governance heading into a future of mounting shocks, finding widespread gains in public-goods provision from 2000 to 2023 even as democratic accountability edged down and state capacity showed little overall improvement. The BGI, presented Wednesday by an international group of governance scholars, analyses measurable benchmarks of democratic accountability across 145 countries. On a 100-point scale, the global score for democratic accountability slipped slightly from 65 in 2000 to 64 in 2023, the most recent data used in the project. The wave of democratisation observed in the closing decades of the last century has stalled in the last 15 years. Democratic accountability fell in 54 countries while it improved in 48 countries. Yet the BGI — a collaborative project of the Luskin School of Public Affairs at the University of California, Los Angeles (UCLA), Berlin’s Hertie School an

BIK Behavioural Verification technology as the response to the growing wave of digital fraud in the African financial market5.5.2026 09:00:00 CEST | Press release

05.05.2026, Warsaw, POLAND - Biuro Informacji Kredytowej (BIK), Credit Information Bureau, the leading organization in Poland for credit data exchange and anti-fraud systems, has formed a strategic alliance with Fair Score Africa. Fair Score Africa is an Award Winning pioneer in credit repair and re-integration, alternative credit scoring and in tackling financial exclusion, based in South Africa. This collaboration aims to implement the Polish-developed BIK Behavioural Verification Platform in seven key African markets, with the goal of reducing financial fraud. Amidst the rapid digitalization of financial services across Africa, an increase in fraudulent activities is threatening transaction security and emerging as a significant challenge to the stability of developing economies.

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye